Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment
Glia · 2024
DOI: 10.1002/glia.24481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Katharine E Askew und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Cerebrovascular Disorders, Cognition Disorders, Cognitive Dysfunction, Leukoencephalopathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Alzheimer's Society, Medical Research Council UK.
Abstract (Originalsprache)
White matter abnormalities, related to poor cerebral perfusion, are a core feature of small vessel cerebrovascular disease, and critical determinants of vascular cognitive impairment and dementia. Despite this importance there is a lack of treatment options. Proliferation of microglia producing an expanded, reactive population and associated neuroinflammatory alterations have been implicated in the onset and progression of cerebrovascular white matter disease, in patients and in animal models, suggesting that targeting microglial proliferation may exert protection. Colony‐stimulating factor‐1 receptor (CSF1R) is a key regulator of microglial proliferation. We found that the expression of CSF1R/Csf1r and other markers indicative of increased microglial abundance are significantly elevated in damaged white matter in human cerebrovascular disease and in a clinically relevant mouse model of chronic cerebral hypoperfusion and vascular cognitive impairment. Using the mouse model, we investigated long‐term pharmacological CSF1R inhibition, via GW2580, and demonstrated that the expansion of microglial numbers in chronic hypoperfused white matter is prevented. Transcriptomic analysis of hypoperfused white matter tissue showed enrichment of microglial and inflammatory gene sets, including phagocytic genes that were the predominant expression modules modified by CSF1R inhibition. Further, CSF1R inhibition attenuated hypoperfusion‐induced white matter pathology and rescued spatial learning impairments and to a lesser extent cognitive flexibility. Overall, this work suggests that inhibition of CSF1R and microglial proliferation mediates protection against chronic cerebrovascular white matter pathology and cognitive deficits. Our study nominates CSF1R as a target for the treatment of vascular cognitive disorders with broader implications for treatment of other chronic white matter diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
- UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
- Centre for Clinical Brain Sciences and Sudden Death Brain Bank, University of Edinburgh, Edinburgh, UK.
- British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
- School of Biological Sciences, University of Southampton, Southampton, UK.
- Clinical and Translational Research Institute, Newcastle University, Newcastle, UK.
ORCID-Profile: Karen Horsburgh
Förderung
- Medical Research Council
- Alzheimer's Society
- Medical Research Council UK
- UK Dementia Research Institute
Zitieren
APA
Askew, K. E., Beverley, J., Sigfridsson, E., Szymkowiak, S., Emelianova, K., Dando, O., Hardingham, G. E., Duncombe, J., Hennessy, E., Koudelka, J., Samarasekera, N., Salman, R. A., Smith, C., Tavares, A. A. S., Gomez-Nicola, D., Kalaria, R. N., McColl, B. W., & Horsburgh, K. (2024). Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment. Glia. https://doi.org/10.1002/glia.24481
Vancouver
Askew KE, Beverley J, Sigfridsson E, Szymkowiak S, Emelianova K, Dando O, et al. Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment. Glia. 2024. doi:10.1002/glia.24481
BibTeX
@article{Askew2024,
author = {Askew, Katharine E and Beverley, Joshua and Sigfridsson, Emma and Szymkowiak, Stefan and Emelianova, Katherine and Dando, Owen and Hardingham, Giles E and Duncombe, Jessica and Hennessy, Edel and Koudelka, Juraj and Samarasekera, Neshika and Salman, Rustam Al-Shahi and Smith, Colin and Tavares, Adriana A S and Gomez-Nicola, Diego and Kalaria, Raj N and McColl, Barry W and Horsburgh, Karen},
title = {Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment},
journal = {Glia},
year = {2024},
doi = {10.1002/glia.24481}
}
EUVIMED